SMS Pharmaceuticals Share Price | SMS Pharmaceuticals Stock Screener
SMSPHARMA
Pharmaceuticals
Share Price NSE
₹381.10
▼
-3.55 (-0.92%)
Share Price BSE
₹380.80
▼
-4.15 (-1.08%)
As of July 24, 2026, the SMS Pharmaceuticals share price (NSE: SMSPHARMA) is ₹381.10 on NSE and ₹380.80 on BSE, down 0.92% from the previous close, with shares trading between ₹378.30 and ₹386.00, and a 52-week range of ₹214.71–₹438.30.
Analyse SMSPHARMA share price history and track historical price performance.
Use the SMS Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
SMS Pharmaceuticals Market Cap
₹3,600.50 Cr.
SMSPHARMA P/E Ratio (TTM)
35.31
SMS Pharmaceuticals P/B Ratio
4.58
EPS (TTM)
₹11.15
Dividend Yield
0.10%
Debt to Equity
0.50
SMSPHARMA 52 Week High
₹438.30
SMS Pharmaceuticals 52 Week Low
₹214.71
Operating Margin
17.00%
Profit Margin
13.69%
SMSPHARMA Revenue (TTM)
₹241.00
EBITDA
₹43.00
Net Income
₹33.00
Total Assets
₹1,362.00
Total Equity
₹786.00
SMS Pharmaceuticals Share Price Chart
Screen SMS Pharmaceuticals share price with an interactive chart. Analyse SMSPHARMA price trends and volatility across different timeframes.
SMS Pharmaceuticals Company Profile - Fundamental Screener
Screen SMS Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SMSPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE812G01025
SMS Pharmaceuticals Balance Sheet Screener
Screen SMSPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,362 | 1,153 | 1,034 | 880 | 860 | 812 | 608 | 559 | 503 | 493 |
| Current Assets | 638 | 555 | 534 | 411 | 377 | 309 | 219 | 208 | 169 | 157 |
| Fixed Assets | 656 | 533 | 437 | 412 | 438 | 457 | 281 | 281 | 279 | 291 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 224 | 189 | 166 | 164 | 193 | 206 | 115 | 94 | 97 | 91 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 786 | 640 | 536 | 461 | 470 | 411 | 348 | 322 | 285 | 255 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 776 | 615 | 499 | 452 | 462 | 402 | 340 | 314 | 276 | 246 |
SMS Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen SMS Pharmaceuticals income statement and profit fundamentals.
Analyze SMSPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for SMS Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 241 | 214 | 244 | 197 | 250 | 176 | 198 | 166 | 248 | 163 | 167 | 136 | 151 | 151 | 160 |
| Expenses | 198 | 167 | 194 | 157 | 207 | 140 | 165 | 131 | 212 | 133 | 139 | 109 | 126 | 130 | 146 |
| EBITDA | 43 | 47 | 50 | 40 | 42 | 35 | 33 | 35 | 35 | 31 | 29 | 27 | 25 | 21 | 14 |
| Operating Profit % | 17.00% | 21.00% | 20.00% | 20.00% | 16.00% | 19.00% | 16.00% | 20.00% | 14.00% | 18.00% | 17.00% | 19.00% | 16.00% | 12.00% | 9.00% |
| Depreciation | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Interest | 5 | 6 | 6 | 6 | 5 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 5 |
| Profit Before Tax | 27 | 31 | 34 | 24 | 29 | 22 | 20 | 22 | 22 | 17 | 15 | 13 | 11 | 7 | 1 |
| Tax | -6 | 8 | 9 | 4 | 8 | 4 | 5 | 5 | 5 | 5 | 3 | 3 | 4 | 3 | 3 |
| Net Profit | 33 | 24 | 25 | 21 | 20 | 18 | 14 | 17 | 17 | 12 | 12 | 9 | 6 | 4 | -2 |
| EPS | 3.58 | 2.59 | 2.84 | 2.31 | 2.40 | 2.15 | 1.67 | 1.95 | 2.04 | 1.36 | 1.39 | 1.10 | 0.73 | 0.44 | -0.24 |
SMS Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SMSPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 82 | 50 | 23 | 45 | 90 | 40 | 50 | 32 | 74 | 61 |
| Investing Activities | -123 | -52 | -30 | -27 | -152 | -43 | -35 | -17 | -39 | -97 |
| Financing Activities | 47 | 31 | -32 | -12 | 92 | -2 | -13 | -15 | -33 | 27 |
| Net Cash Flow | 5 | 29 | -39 | 6 | 31 | -5 | 2 | 0 | 1 | -9 |
SMS Pharmaceuticals Shareholding Pattern Screener
See SMS Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check SMS Pharmaceuticals promoter holding and ownership changes for SMSPHARMA on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.07% | 68.07% | 68.07% | 68.07% | 66.26% | 66.26% | 64.67% | 64.67% |
| FII Holding | 0.65% | 0.31% | 0.04% | 0.28% | 0.03% | 0.08% | 0.31% | 0.52% |
| DII Holding | 2.83% | 3.02% | 3.21% | 2.88% | 3.03% | 2.43% | 2.55% | 2.55% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.04% | 23.17% | 24.08% | 24.02% | 25.89% | 26.35% | 27.38% | 27.04% |
| Other Holding | 4.41% | 5.43% | 4.61% | 4.76% | 4.78% | 4.87% | 5.09% | 5.23% |
| Shareholder Count | 31,489 | 32,397 | 34,378 | 33,009 | 33,652 | 35,332 | 34,973 | 33,136 |
SMS Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check SMS Pharmaceuticals dividend history with payout and yield data.
View SMS Pharmaceuticals dividend details including ex-dates and amounts for SMSPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.40 | 0.11% |
| 2024-March | ₹0.40 | 0.19% |
| 2023-March | ₹0.30 | 0.17% |
| 2022-March | ₹0.30 | 0.53% |
| 2021-March | ₹0.30 | 0.32% |
| 2020-March | ₹0.25 | 0.20% |
| 2019-March | ₹0.25 | 0.93% |
| 2018-March | ₹0.25 | 0.40% |
| 2017-March | ₹0.20 | 0.27% |
SMS Pharmaceuticals Stock Index Membership
See which indices include SMS Pharmaceuticals stock.
Check SMSPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
SMS Pharmaceuticals Market Events Screener - Corporate Actions
Get SMS Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check SMS Pharmaceuticals stock events that may affect SMSPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 6.36% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 0.44% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | 0.91% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 12.38% |
| 2025-09-22 | 2025-09-22 | Dividend | ₹ 0.40 /share | 8.19% |
| 2025-08-09 | 2025-08-09 | Quarterly Result Announcement | NA | -2.17% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 3.00% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -2.50% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 3.84% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 12.37% |
| 2024-09-23 | 2024-09-23 | Dividend | ₹ 0.40 /share | 75.63% |
| 2024-03-06 | 2024-03-06 | Extraordinary General Meeting | NA | 24.21% |
| 2023-09-22 | 2023-09-22 | Dividend | ₹ 0.30 /share | 43.96% |
| 2022-09-22 | 2022-09-23 | Dividend | ₹ 0.30 /share | 6.46% |
| 2021-09-22 | 2021-09-24 | Dividend | ₹ 0.30 /share | -5.91% |
SMS Pharmaceuticals Competitors Screener - Peer Comparison
Screen SMSPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 469,406 | 40.78 | 61,674 | 12.69% | 11,565 | 67.08 |
| Divis Laboratories | 194,270 | 75.69 | 11,067 | 13.95% | 2,568 | 71.64 |
| Torrent Pharmaceuticals | 190,389 | 79.19 | 13,886 | 20.34% | 2,138 | 65.32 |
| Cipla | 116,459 | 30.16 | 29,045 | 2.24% | 3,870 | 55.65 |
| Zydus Life Science | 115,616 | 22.33 | 27,658 | 17.64% | 5,026 | 60.58 |
| Lupin | 113,325 | 21.16 | 29,039 | 26.75% | 5,356 | 59.41 |
| Mankind Pharma | 105,967 | 54.68 | 14,636 | 14.85% | 1,938 | 59.45 |
| Dr Reddys Laboratories | 102,088 | 24.56 | 35,059 | 3.90% | 4,158 | 35.59 |
| Aurobindo Pharma | 89,736 | 25.88 | 33,385 | 3.21% | 3,376 | 55.50 |
| Laurus Labs | 84,158 | 94.61 | 6,868 | 22.01% | 890 | 63.63 |
SMS Pharmaceuticals Company Announcements - News Screener
Screen SMSPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015. | - | |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-01 | Clarification On Volume/Price Movement | - |
| 2026-07-01 | Clarification sought from SMS Pharmaceuticals Ltd | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-05 | Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015. | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Change in Registered Office Address | - |
| 2026-05-22 | Statement Of Deviation & Variation For The Quarter Ended 31St March 2026 | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-05-22 | Financial Results For The 4Th Quarter And Year Ended 31St March 2026 | - |
| 2026-05-22 | Board Meeting Outcome for Approval Of Financial Results For The Fourth Quarter And Year Ended 31St March 2026 | - |
| 2026-05-16 | Board Meeting Intimation for Approval Of Financial Results For The Quarter And Financial Year Ended 31St March 2026 | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |